Health & Fitness
Wed, February 22, 2012
DUBLIN, Calif.--([ BUSINESS WIRE ])--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced its Annual Analyst and Investor Day will take place from 10 am to 1 pm ET on Tuesday, March 27th in New York.
During this event, James S.J. Manuso, PhD, chairman and chief executive officer, and Astexas management team will provide updates on the Companyas business, clinical and discovery efforts.
Investors and interested parties may access the webcast in the Investor Events section of the Company's website, [ www.astx.com ]. A webcast replay will be available for 90 days following the live event.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit [ http://www.astx.com ].
